Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Buy
2,708
+2
+0.1% +$234 0.07% 137
2026
Q1
$325K Sell
2,706
-232
-8% -$26.8K 0.07% 136
2025
Q4
$309K Buy
2,938
+277
+10% +$26K 0.08% 135
2025
Q3
$223K Buy
2,661
+4
+0.2% +$329 0.06% 158
2025
Q2
$210K Sell
2,657
-37
-1% -$2.94K 0.06% 164
2025
Q1
$242K Sell
2,694
-20
-0.7% -$1.87K 0.08% 138
2024
Q4
$270K Sell
2,714
-38
-1% -$3.92K 0.09% 123
2024
Q3
$312K Sell
2,752
-20
-0.7% -$2.38K 0.1% 115
2024
Q2
$343K Buy
2,772
+1
+0% +$129 0.12% 98
2024
Q1
$366K Buy
2,771
+2
+0.1% +$247 0.13% 94
2023
Q4
$302K Buy
2,769
+1
+0% +$104 0.12% 106
2023
Q3
$285K Sell
2,768
-198
-7% -$21.3K 0.13% 107
2023
Q2
$342K Buy
2,966
+201
+7% +$22.8K 0.15% 95
2023
Q1
$294K Buy
2,765
+2
+0.1% +$216 0.14% 106
2022
Q4
$307K Sell
2,763
-45
-2% -$4.6K 0.15% 104
2022
Q3
$242K Sell
2,808
-228
-8% -$20.4K 0.15% 108
2022
Q2
$277K Sell
3,036
-4,132
-58% -$366K 0.16% 93
2022
Q1
$588K Sell
7,168
-155
-2% -$12.2K 0.31% 56
2021
Q4
$561K Sell
7,323
-98
-1% -$7.81K 0.27% 63
2021
Q3
$557K Buy
7,421
+62
+0.8% +$4.71K 0.28% 61
2021
Q2
$572K Buy
+7,359
New +$547K 0.3% 57
2020
Q3
Sell
-3,331
Closed -$246K 93
2020
Q2
$246K Buy
3,331
+3
+0.1% +$226 0.19% 79
2020
Q1
$244K Buy
3,328
+2
+0.1% +$157 0.22% 70
2019
Q4
$289K Buy
+3,326
New +$273K 0.21% 79

Other funds holding MRK

Detalus Advisors's MRK Position: Q2 2026 in Review

Detalus Advisors increased its Merck (MRK) stake by 0.07% in Q2 2026, buying an estimated $234 and bringing the position to 2,708 shares worth $348K. The position accounts for 0.07% of the portfolio, ranked #137.

Detalus Advisors first reported a position in MRK in Q4 2019 and has held it in 24 quarters since. The position peaked at $588K in Q1 2022. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Detalus Advisors held 2,708 shares of Merck worth $348K as of Q2 2026.
  • Detalus Advisors bought 2 Merck shares in Q2 2026, an estimated $234.
  • Merck made up 0.07% of Detalus Advisors's portfolio in Q2 2026, its #137 holding.
  • Detalus Advisors first reported a position in Merck in Q4 2019 and has held it in 24 quarters since.
  • Detalus Advisors's Merck position peaked at $588K in Q1 2022.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Detalus Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.